Breaking into the pipeline

摘要

In order to break into the U.S. pharmaceuticalrnindustry, British company BritanniarnPharmaceuticals is changing the rules withrnstrategic partnerships and successful FDArnapprovals.rnMarketing drugs in the United Statesrnrequires a good deal of legwork with thernFDA, as a product dances through the insrnand outs of the approval process. This situationrnmakes it hard for smaller, non-U.S.rncompanies to enter the U.S. market. Theyrnoften lack the experience and guidance tornmake the process work.